Additionally, the results show a significantly higher level of G-CSF in the first passage of the control mice compared to the CIP-treated one, which indicates a stronger PMN recruitment in the control mice, in contrast to a possible stronger mononuclear cells MNCs cell activation in the CIP-treated group. This evidence concerns the gene CSF3 and hereditary sensory and autonomic neuropathy.